Why is this study being conducted?
The purpose of this study is to evaluate a potential new treatment for knee osteoarthritis pain. This treatment is called pentosan polysulfate sodium (PPS) and will be compared to placebo in this trial.
Who is eligible to participate in this study?
You may be eligible if you:
- Are 18 years of age or older
- Have a diagnosis of osteoarthritis in the knee
- Have already been treated with other medicines for at least 6 months, which did not relieve your pain
Applicants who express interest in participating in this study will be reviewed and contacted as other requirement criteria must also be met.
What happens during the study?聽
Trial duration will be up to 64 weeks and participants will have at least 13 trial visits
Trial site visits will occur at the Griffith University Clinical Trial Unit on the Gold Coast.
You will be assigned at random to receive either the study treatment or placebo injections twice weekly for 6 weeks.
Volunteer to participate
Participation in this study is completely voluntary, and participants can decide to withdraw at any time.
Eligible participants will be reimbursed for their time and travel associated with each study visit.
Contact Natalie Lovelock
To learn more about this clinical trial, please contact:
Natalie Lovelock, Clinical Trial Coordinator.
07 5672 7260 clinicaltrialunit@griffith.edu.au
This study has been approved by Bellberry Limited #2024-12-2140 and GU HREC #2025/491.
Can't see a trial for you?
Join our volunteer database to be contacted about new clinical trials